Adhikary S, Caprioli D, Venniro M, Kallenberger P, Shaham Y, Bossert JM (2017) Incubation of extinction responding and cue-induced reinstatement, but not context- or drug priming-induced reinstatement, after withdrawal from methamphetamine. Addict Biol 22:977–990

Article  CAS  PubMed  Google Scholar 

Bakhti-Suroosh A, Towers EB, Lynch WJ (2021) A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse. Psychopharmacology 238:1029–1046

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker JB, Chartoff E (2019) Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology 44:166–183

Article  CAS  PubMed  Google Scholar 

Blasig J, Herz A, Reinhold K, Zieglgansberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19–38

Article  CAS  PubMed  Google Scholar 

Borruto AM, Fotio Y, Stopponi S, Petrella M, De Carlo S, Domi A, Ubaldi M, Weiss F, Ciccocioppo R (2021) NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats. Neuropsychopharmacology 46:2121–2131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bossert J, Liu S, Lu L, Shaham Y (2004) A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24:10726–10730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bossert JM, Hoots JK, Fredriksson I, Adhikary S, Zhang M, Venniro M, Shaham Y (2019) Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking. Eur J Neurosci 50:2075–2085

Article  PubMed  Google Scholar 

Bossert JM, Kiyatkin E, Korah H, Hoots JK, Afzal A, Perekopskiy D, Thomas S, Fredriksson I, Blough BE, Negus SS, Epstein DH, Shaham Y (2020) In a rat model of opioid maintenance, the G-protein-biased MOR agonist TRV130 decreases relapse to oxycodone seeking and taking, and prevents oxycodone-induced brain hypoxia. Biol Psychiatry 88:935–944

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bossert JM, Townsend EA, Altidor LK, Fredriksson I, Shekara A, Husbands S, Sulima A, Rice KC, Banks ML, Shaham Y (2022) Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance. Br J Pharmacol 179:227–241

Article  CAS  PubMed  Google Scholar 

Butelman ER, Huang Y, Epstein DH, Shaham Y, Goldstein RZ, Volkow ND, Alia-Klein N (2023) Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis. Neuropsychopharmacology 48(11):1639–1647

Calu DJ, Chen YW, Kawa AB, Nair SG, Shaham Y (2014) The use of the reinstatement model to study relapse to palatable food seeking during dieting. Neuropharmacology 76 Pt B:395–406

Cannella N, Lunerti V, Shen Q, Li H, Benvenuti F, Soverchia L, Narendran R, Weiss F, Ciccocioppo R (2024) Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy. Neuropharmacology 257:110048

Article  CAS  PubMed  Google Scholar 

Caprioli D, Venniro M, Zeric T, Li X, Adhikary S, Madangopal R, Marchant NJ, Lucantonio F, Schoenbaum G, Bossert JM, Shaham Y (2015) Effect of the novel positive allosteric modulator of metabotropic glutamate receptor 2 AZD8529 on incubation of methamphetamine craving after prolonged voluntary abstinence in a rat model. Biol Psychiatry 78:463–473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cerletti C, Keinath SH, Reidenbery MM, Alder MW (1976) Chronic morphine administration: plasma levels and withdrawal syndrome in rats. Pharmacol Biochem Behav 4:323–327

Article  CAS  PubMed  Google Scholar 

Ciccocioppo R, Angeletti S, Sanna PP, Weiss F, Massi M (2000) Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol 404:153–159

Article  CAS  PubMed  Google Scholar 

Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ (2000) Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology 150:430–442

Article  CAS  PubMed  Google Scholar 

Craft RM (2008) Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids. Exp Clin Psychopharmacol 16:376–385

Article  CAS  PubMed  Google Scholar 

Crombag H, Shaham Y (2002) Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behav Neurosci 116:169–173

Article  CAS  PubMed  Google Scholar 

Dasgupta P, Mann A, Polgar WE, Reinscheid RK, Zaveri NT, Schulz S (2022) Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics. Sci Rep 12:7154

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen XT, Pitis PM, Gotchev D, Yuan C, Koblish M, Lark MW, Violin JD (2013) A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344:708–717

Article  CAS  PubMed  Google Scholar 

Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC (2016) A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Proc Natl Acad Sci USA 113:E5511–E5518

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding H, Kiguchi N, Yasuda D, Daga PR, Polgar WE, Lu JJ, Czoty PW, Kishioka S, Zaveri NT, Ko MC (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:1–11

Article  Google Scholar 

Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 189:1–16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Epstein DH, Heilig M, Shaham Y (2018) Science-based actions can help address the opioid crisis. Trends Pharmacol Sci 39:911–916

Article  CAS  PubMed  Google Scholar 

Fredriksson I, Applebey SV, Minier-Toribio A, Shekara A, Bossert JM, Shaham Y (2020) Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence. Neuropsychopharmacology 45:770–779

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fredriksson I, Venniro M, Reiner DJ, Chow JJ, Bossert JM, Shaham Y (2021) Animal models of drug relapse and craving after voluntary abstinence: A review. Pharmacol Rev 73:1050–1083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hedegaard H, Warner M, Minino AM (2017) Drug Overdose Deaths in the United States, 1999–2016. NCHS Data Brief:1–8.

Jaffe JH (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 522–573

Google Scholar 

Kallupi M, Scuppa G, de Guglielmo G, Calo G, Weiss F, Statnick MA, Rorick-Kehn LM, Ciccocioppo R (2017) Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction. Neuropsychopharmacology 42:695–706

Article  CAS  PubMed  Google Scholar 

Kallupi M, Shen Q, de Guglielmo G, Yasuda D, Journigan VB, Zaveri NT, Ciccocioppo R (2018) Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption. Addict Biol 23:585–595

Article  CAS  PubMed  Google Scholar 

Khroyan TV, Zaveri NT, Polgar WE, Orduna J, Olsen C, Jiang F, Toll L (2007) SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice. J Pharmacol Exp Ther 320:934–943

Article  CAS  PubMed